Edition:
United States

Rocket Pharmaceuticals Inc (RCKT.OQ)

RCKT.OQ on NASDAQ Stock Exchange Global Market

19.92USD
2:22pm EDT
Change (% chg)

$-0.06 (-0.30%)
Prev Close
$19.98
Open
$20.03
Day's High
$20.33
Day's Low
$19.67
Volume
21,967
Avg. Vol
104,294
52-wk High
$24.20
52-wk Low
$3.56

Chart for

About

Rocket Pharmaceuticals, Inc., formerly Inotek Pharmaceuticals Corporation, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. Its lead product candidate, trabodenoson, is a selective adenosine mimetic... (more)

Overall

Beta: 3.95
Market Cap(Mil.): $805.01
Shares Outstanding(Mil.): 39.48
Dividend: --
Yield (%): --

Financials

  RCKT.OQ Industry Sector
P/E (TTM): -- 217.69 33.34
EPS (TTM): -3.21 -- --
ROI: -21.19 -3.65 13.18
ROE: -29.28 -5.62 15.09

BRIEF-Rocket Pharmaceuticals Presents Updated Data From Phase 1/2 Gene Therapy Trial Of Rp-L102

* ROCKET PHARMACEUTICALS PRESENTS UPDATED DATA FROM PHASE 1/2 GENE THERAPY TRIAL OF RP-L102 IN PATIENTS WITH FANCONI ANEMIA AT THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT) ANNUAL MEETING

May 18 2018

BRIEF-Rocket Pharmaceuticals Announces Strategic Research Collaboration

* ROCKET PHARMACEUTICALS ANNOUNCES STRATEGIC RESEARCH COLLABORATION

May 17 2018

BRIEF-Rocket Pharma Appoints Former FDA Staffer As VP Of Regulatory Policy And Patient Advocacy

* ROCKET PHARMACEUTICALS APPOINTS GAYATRI R. RAO, M.D., J.D., FORMER U.S. FOOD AND DRUG ADMINISTRATION DIRECTOR OF THE OFFICE OF ORPHAN PRODUCTS DEVELOPMENT, AS VICE PRESIDENT, REGULATORY POLICY AND PATIENT ADVOCACY Source text for Eikon: Further company coverage:

May 15 2018

BRIEF-Rocket Pharmaceuticals Reports Q1 Loss Per Share Of $0.42

* ROCKET PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

May 11 2018

Rocket-control glitch delays launch of NASA's planet-hunting satellite

CAPE CANAVERAL, Fla. An 11th-hour technical glitch prompted SpaceX to postpone its planned launch on Monday of a new NASA space telescope designed to detect worlds beyond our solar system, delaying for at least 48 hours a quest to expand astronomers' known inventory of so-called exoplanets.

Apr 16 2018

BRIEF-Rocket Pharmaceuticals Reports Full-Year 2017 Results

* ROCKET PHARMACEUTICALS REPORTS FULL YEAR 2017 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

Mar 06 2018

BRIEF-Rocket Pharmaceuticals Prices Public Offering Of Common Stock

* ROCKET PHARMACEUTICALS PRICES PUBLIC OFFERING OF COMMON STOCK

Jan 24 2018

BRIEF-Rocket Pharmaceuticals Announces Proposed Public Offering Of Common Stock

* ROCKET PHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

Jan 23 2018

Earnings vs. Estimates